Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy

por Liu, Zi-Ning, Wang, Yin-Kui, Zhang, Li, Jia, Yong-Ning, Fei, Shan, Ying, Xiang-Ji, Zhang, Yan, Li, Shuang-Xi, Sun, Yu, Li, Zi-Yu, Ji, Jia-Fu
Publicado 2021

The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer

por Chen, Jun-Bing, Liu, Zi-Ning, Wang, Yin-Kui, Shan, Fei, Li, Shuang-Xi, Jia, Yong-Ning, Xue, Kan, Miao, Ru-Lin, Li, Zhe-Min, Wu, Zhou-Qiao, Ying, Xiang-Ji, Zhang, Yan, Li, Zi-Yu, Ji, Jia-Fu
Publicado 2022

Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer

por Fan, Biao, Zhang, Lian-Hai, Jia, Yong-ning, Zhong, Xi-Yao, Liu, Yi-Qiang, Cheng, Xiao-Jing, Wang, Xiao-Hong, Xing, Xiao-Fang, Hu, Ying, Li, Ying-Ai, Du, Hong, Zhao, Wei, Niu, Zhao-Jian, Lu, Ai-Ping, Li, Ji-You, Ji, Jia-Fu
Publicado 2012

ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7

por Guo, Ting, Wen, Xian-Zi, Li, Zi-yu, Han, Hai-bo, Zhang, Chen-guang, Bai, Yan-hua, Xing, Xiao-Fang, Cheng, Xiao-jing, Du, Hong, Hu, Ying, Wang, Xiao-Hong, Jia, Yong-Ning, Nie, Meng-Lin, Xie, Meng, Li, Qing-Da, Ji, Jia-Fu
Publicado 2019